Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda

被引：8

作者：

Ebina, K. ^{[1
]}

Hashimoto, J. ^{[2
]}

Shi, K. ^{[1
]}

Kashii, M. ^{[1
]}

Hirao, M. ^{[1
]}

Yoshikawa, H. ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan

[2] Natl Hosp Org, Dept Rheumatol, Osaka Minami Med Ctr, Kawachi Nagano, Osaka 5868521, Japan

来源：

OSTEOPOROSIS INTERNATIONAL | 2015年 / 26卷 / 04期

关键词：

RHEUMATOID-ARTHRITIS;

D O I：

10.1007/s00198-014-2993-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1445 / 1445

页数：1

共 4 条

[1] The role of osteocalcin in human glucose metabolism: marker or mediator? [J].

Booth, Sarah L. ;

Centi, Amanda ;

Smith, Steven R. ;

Gundberg, Caren .

NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (01) :43-55

[2] Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients [J].

Ebina, K. ;

Hashimoto, J. ;

Shi, K. ;

Kashii, M. ;

Hirao, M. ;

Yoshikawa, H. .

OSTEOPOROSIS INTERNATIONAL, 2014, 25 (12) :2755-2765

[3] Serum undercarboxylated osteocalcin level increases with 48 weeks of teriparatide treatment in pre-treated elderly rheumatoid arthritis patients who use anti-resorptive drugs [J].

Mokuda, S. ;

Sawada, N. ;

Matoba, K. ;

Yamada, A. ;

Onishi, M. ;

Okuda, Y. ;

Jouyama, K. ;

Murata, Y. ;

Takasugi, K. .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (09) :796-799

[4]

Mokuda S, 2014, UNDERCARBOXYLATED OS, DOI [10.1007/s00198-014-2958-0, DOI 10.1007/S00198-014-2958-0]

← 1 →